Hanson & Doremus Investment Management Purchases New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hanson & Doremus Investment Management bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 440 shares of the medical equipment provider's stock, valued at approximately $230,000.

Other hedge funds have also modified their holdings of the company. Bennett Selby Investments LP increased its position in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after buying an additional 17 shares in the last quarter. LVW Advisors LLC boosted its stake in shares of Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after acquiring an additional 19 shares during the last quarter. Wesbanco Bank Inc. increased its stake in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after acquiring an additional 19 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its stake in shares of Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock valued at $177,000 after purchasing an additional 20 shares in the last quarter. Finally, Mitchell Mcleod Pugh & Williams Inc. increased its holdings in Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider's stock valued at $247,000 after purchasing an additional 20 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jamie Samath sold 269 shares of the stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now directly owns 8,757 shares of the company's stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock worth $15,357,560 in the last quarter. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent analyst reports. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research note on Thursday, October 17th. Truist Financial lifted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a "buy" rating in a report on Friday, January 24th. UBS Group boosted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday. Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Finally, Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus price target of $613.10.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded up $10.27 during midday trading on Thursday, reaching $582.98. The company's stock had a trading volume of 931,517 shares, compared to its average volume of 1,958,470. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The business's fifty day simple moving average is $549.32 and its 200-day simple moving average is $507.50. The company has a market capitalization of $207.65 billion, a P/E ratio of 93.73, a P/E/G ratio of 5.19 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.